ZURICH | Mon Jun 29 , 2009 1:58 pm EDT ZURICH -LRB- Reuters -RRB- - A patient with H1N1 influenza in Denmark showed resistance to Roche Holding AG 's Tamiflu , the main antiviral flu drug , a company executive said on Monday . 
`` While receiving the drug , the patient appeared to develop resistance to it , '' David Reddy , Roche 's pandemic taskforce leader , told reporters on a conference call on the Danish case . 
`` This is the first report we have of it in H1N1 . '' 
The World Health Organization has raised its pandemic flu alert on the H1N1 flu virus to phase 6 on a six-point scale , indicating the first influenza pandemic since 1968 is under way . 
Common seasonal flu can resist Tamiflu and Reddy said a case of resistance in H1N1 was not unexpected , adding Roche has been working on strategies to counter such a development . 
-LRB- Reporting by Sam Cage and Paul Arnold ; Editing by David Holmes -RRB- An ultra-low latency infrastructure for electronic trading and data distribution A connected approach to governance , risk and compliance Our next generation legal research platform 
